Pfizer Celebrex Sales Reps Will Discuss Alternate Therapy, FDA Says

Pfizer will include FDA’s recommendation that prescribers consider alternative therapy in its promotion to doctors. The company has also agreed to suspend direct-to-consumer advertising for the COX-2 inhibitor following release of trial data showing an increased cardiovascular risk for patients on the drug.